Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.

R C Ishizawar1, T Miyake, S J Parsons

  • 1Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, VA 22908, USA.

Oncogene
|December 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Oncogene·2012
Same author

Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.

Oncogene·2011
Same author

Fluctuations in cosmic radiation at radio-frequencies.

Nature·2010
Same author

Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.

Oncogene·2006
Same author

Paediatric empyema: a case report and literature review.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2006
Same author

Clostridium difficile associated severe enterocolitis: a feature of Hirschsprung's disease in a neonate presenting late.

Journal of paediatrics and child health·2006
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

The study reveals that c-Src kinase enhances the interaction between ErbB2 and ErbB3 receptors, boosting breast cancer cell growth and motility. Inhibiting c-Src disrupts this oncogenic signaling pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Overexpression of c-Src and epidermal growth factor receptor (EGFR/ErbB) family members is linked to breast cancer development.
  • EGFR/ErbB family members form heterocomplexes, and c-Src physically interacts with them in breast cancer.
  • The ErbB2/ErbB3 heterocomplex exhibits significant oncogenic potential.

Purpose of the Study:

  • To investigate the role of c-Src in modulating the physical and functional interaction between ErbB2 and ErbB3.
  • To determine if c-Src acts upstream or downstream of ErbB2/ErbB3 signaling.
  • To elucidate the impact of c-Src on the oncogenic functions mediated by the ErbB2/ErbB3 heterocomplex.

Main Methods:

  • Overexpression of wild-type and kinase-inactive c-Src (K(-) c-Src) in breast cancer cells.

Related Experiment Videos

  • Pharmacological inhibition of c-Src using PP2.
  • Assessment of ErbB2/ErbB3 heterocomplex formation and receptor activation.
  • Evaluation of downstream signaling pathways and cellular functions like motility and anchorage-independent growth.

    • Main Results:

    • Overexpressed wild-type c-Src enhances ErbB2/ErbB3 heterocomplex formation.
    • This enhancement leads to increased basal and heregulin-induced activation of ErbB2/ErbB3 and downstream effectors.
    • Inhibition or inactivation of c-Src abrogates ErbB2/ErbB3-mediated cellular motility and anchorage-independent growth.
    • c-Src positively modulates ErbB2/ErbB3 association, suggesting an upstream role.

    Conclusions:

    • c-Src plays a critical upstream role in enhancing ErbB2/ErbB3 signaling and oncogenic functions in breast cancer.
    • Modulation of ErbB2/ErbB3 association by c-Src is a key mechanism driving tumor progression.
    • Targeting c-Src may represent a therapeutic strategy for breast cancers driven by ErbB2/ErbB3 signaling.